FIKSIROVANNAYa KOMBINATsIYa BISOPROLOLA I AMLODIPINA: NOVYE VOZMOZhNOSTI ANTIGIPERTENZIVNOY TERAPII
- Authors: Nedogoda S.V1
-
Affiliations:
- Issue: No 6 (2013)
- Pages: 90-97
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/280626
- ID: 280626
Cite item
Open Access
Access granted
Abstract
The article discusses the problem of the treatment of hypertensive patients using optimal combinations of antihypertensive drugs. The results of numerous studies on the use of different groups of antihypertensive drugs, including β-blockers (bisoprolol), calcium channel blocker (amlodipine), and their combinations are analyzed.
Full Text
References
- Чазова И.Е., Бойцов С.А., Небиеридзе Д.В. Основные положения проекта второго пересмотра рекомендаций ВНОК по профилактике, диагностике и лечению артериальной гипертензии // Кардиоваск. терапия и профилактика 2004. № 4. С. 90-8.
- A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation 1994;90(4):1765-63.
- Beevers DG. The end of blockers for uncomplicated hypertension? Lancet 2005; DOI:1.
- Buhler FR, Berglund G, Anderson OK, et al. Double-blind comparison of the car-dioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS). J Cardiovasc Pharmacol 1986;8(Suppl. 11):122-27.
- Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet 2004;364:1684-89.
- CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 1999; 353(9146):9-13.
- DeMuinck ED, Buchner-Moell D, van de Ven LL, Lie KI. Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina pectoris (MIRSA). J Cardiovasc Pharmacol 1992;19(6):870-75.
- van Zweiten PA. Beneficial combinations of two or more antihypertensive drugs. European Society of Hypertension Scientific Newsletter 2003;4(16).
- Gosse P, Roudaut R, Herrero G, Dallocchio M. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy J Cardiovasc Pharmacol 1990;16(Suppl. 5):145-50.
- Haasis R, Bethge H. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of trearment with bisoprolol and metoprolol: a randomized multicentre double-blind study (BISOMET). Eur Heart J 1987;8 (Suppl. M): 103-13.
- Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low - dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-62.
- Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choise in the treatment of primary hypertension? A meta-analysis. Lancet 2005;D0I:10.1016/S0140-6736(05) 67573-73.
- Page IH. Pathogenesis of arterial hypertension. JAMA 1949;140:451-57.
- Palatini P, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002;162:2313-21.
- Plevan A, Lehmann G, Ndrepepa G, et al. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Eur Heart J 2001;22(16):1504-10.
- Rana R, Patil A. Clinical Perspective on the Management of HypertensionIndian Pract 2008;61:225-34.
- Sever PS, Messerli FH. Hypertension management 2011: optimal combination therapy. Eur Heart J 2011.
- Singh BN. Increased heart rate as a risk factor for cardiovascular disease. Eur Heart J Suppl 2003;5(Suppl. G):G3-G9.
Supplementary files
